Requirement of caspases and p38 MAPK for TRAIL-mediated ICAM-1 expression by human astroglial cells

Area of Science:

• Immunology
• Cell Biology
• Neuroscience

Background:

• Tumor necrosis factor (TNF) superfamily ligands, including TNF-related apoptosis inducing ligand (TRAIL), TNF-alpha, and FasL, are known as death ligands.
• TRAIL exhibits selective cytotoxicity against tumor cells but can also trigger alternative angiogenic and proinflammatory signals.
• The molecular mechanisms underlying these alternative signals, particularly regarding Intercellular Adhesion Molecule-1 (ICAM-1) expression in human astroglial cells, remain underexplored.

Purpose of the Study:

• To investigate the molecular mechanisms responsible for ICAM-1 expression induced by death ligands in human astroglial cells.
• To delineate the alternative signaling pathways activated by death ligands beyond apoptosis.
• To understand the role of ICAM-1 in potential metastatic and angiogenic processes mediated by these ligands.

Main Methods:

• Treatment of human astroglial cells with death ligands.
• Analysis of ICAM-1 expression at both mRNA and protein levels.
• Assessment of monocytic cell adhesion following death ligand treatment.
• Pharmacological inhibition of caspase (z-VAD-fmk) and p38 MAPK (SB202190).
• Evaluation of caspase-dependent and/or p38 MAPK-dependent phosphorylation of key signaling molecules (IKK).

Main Results:

• Death ligands significantly induced ICAM-1 expression at mRNA and protein levels in human astroglial cells.
• Pre-treatment with caspase inhibitor (z-VAD-fmk) and/or p38 MAPK inhibitor (SB202190) suppressed ICAM-1 expression and subsequent activated monocytic cell adhesion.
• Inhibition of caspase activity led to suppressed phosphorylation of p38 MAPK and IKK, indicating a role for caspase in these signaling events.

Conclusions:

• Death ligands activate biological functions in human astroglial cells beyond apoptosis.
• Caspase and p38 MAPK signaling pathways are critically involved in the alternative signaling cascade initiated by death receptors.
• These findings highlight a novel role for death receptors in regulating ICAM-1 expression and potentially influencing inflammatory and angiogenic processes in the glial microenvironment.